Discontinuation of Secondary Prophylaxis forPneumocystis cariniiPneumonia in Human Immunodeficiency Virus–Infected Patients: A Randomized Trial by the CIOP Study Group
Open Access
- 1 March 2003
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (5) , 645-651
- https://doi.org/10.1086/367659
Abstract
To evaluate whether bacterial vaginosis predicts the acquisition of sexually transmitted diseases (STDs), we studied 255 nonpregnant female subjects aged 15–30 who reported recent sexual contact with a male partner in whom either gonococcal or chlamydial urethritis or nongonococcal urethritis was diagnosed. Compared to subjects with normal vaginal flora, subjects with bacterial vaginosis were more likely to test positive for Neisseria gonorrhoeae (odds ratio [OR], 4.1; 95% confidence interval [CI], 1.7–9.7) and Chlamydia trachomatis (OR, 3.4; 95% CI, 1.5–7.8). Subjects colonized vaginally by hydrogen peroxide–producing lactobacilli were less likely to receive a diagnosis of chlamydial infection or gonorrhea than subjects without such lactobacilli. Bacterial vaginosis was a strong predictor of gonorrhea and chlamydial infection among subjects who reported recent exposure to a male partner with urethritis. These data support the importance of vaginal flora in the defense against STD acquisition.Keywords
This publication has 27 references indexed in Scilit:
- A Pilot Study of the Discontinuation of Antifungal Therapy for Disseminated Cryptococcal Disease in Patients with Acquired Immunodeficiency Syndrome, following Immunologic Response to Antiretroviral TherapyThe Journal of Infectious Diseases, 2002
- A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/lAIDS, 2001
- Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapyAIDS, 2000
- Discontinuation of Primary Prophylaxis forPneumocystis cariniiPneumonia and Toxoplasmic Encephalitis in Human Immunodeficiency Virus Type I–Infected Patients: The Changes in Opportunistic Prophylaxis StudyThe Journal of Infectious Diseases, 2000
- Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?AIDS, 1999
- Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Long‐Lasting Remission of Cytomegalovirus Retinitis without Maintenance Therapy in Human Immunodeficiency Virus‐Infected PatientsThe Journal of Infectious Diseases, 1998
- Limited Persistence in and Subsequent Elimination of Pneumocystis carinii from the Lungs after P. carinii PneumoniaThe Journal of Infectious Diseases, 1995
- Legionella andPneumocystis pneumonias in asthmatic children on high doses of systemic steroidsPediatric Pulmonology, 1994